Long Term Care Devices Market by Type (Diagnostic, Mobility Assist, Therapeutic), Product Type (Non-Wearable Devices, Wearable Devices), Distribution Channel, End Users - Global Forecast 2025-2032
Description
The Long Term Care Devices Market was valued at USD 224.05 billion in 2024 and is projected to grow to USD 239.71 billion in 2025, with a CAGR of 7.48%, reaching USD 399.24 billion by 2032.
Strategic context for long-term care devices highlighting clinical shifts, care setting transitions, reimbursement interplay, and technology priorities for product leaders
The long-term care devices sector sits at the intersection of population aging, evolving care delivery models, and accelerating medical technology innovation. Clinicians, caregivers, and procurement leaders increasingly seek devices that enable safe, cost-effective care beyond traditional hospital walls, and that support clinical decision-making at the point of need. As a result, the ecosystem comprises a diverse array of product types and distribution pathways that must meet clinical requirements, regulatory standards, and user experience expectations simultaneously.
In practice, this landscape requires device manufacturers and service providers to think holistically about interoperability, data integrity, and ease of use. Remote monitoring and diagnostics are shifting care pathways toward the home and community settings, while mobility assist and therapeutic devices must balance durability with portability. Moreover, reimbursement frameworks and procurement cycles remain pivotal determinants of adoption. Consequently, stakeholders who align product design with care workflows and payer incentives gain a strategic edge.
Throughout this summary, the emphasis is on pragmatic insights that help leaders prioritize technology, channel, and partnership decisions. The narrative blends clinical, commercial, and regulatory lenses to illuminate how device categories, distribution choices, and regional dynamics shape competitive advantage and operational risk in long-term care.
Key transformative forces reshaping device design, distribution, interoperability expectations, clinical workflows, and supply chain resilience across long-term care settings
Several transformative shifts are redefining how long-term care devices are conceived, procured, and used across care settings. First, digital integration has moved from a differentiator to a baseline expectation: devices must interoperate securely with electronic health records, telehealth platforms, and caregiver dashboards to deliver actionable insights. This is accompanied by a rise in algorithm-enabled decision support that augments clinical workflows while creating new requirements for validation and regulatory clarity.
Second, the balance between wearable and non-wearable devices is evolving as advances in sensor miniaturization and power efficiency increase the clinical utility of wearables, while non-wearable devices continue to serve high-reliability diagnostic and therapeutic roles in institutional settings. Third, distribution dynamics are shifting as online procurement channels expand and hybrid models emerge where direct-to-consumer routes coexist with traditional supplier relationships.
Additionally, workforce constraints and the need for simplified device operation are elevating human-centered design. Companies that streamline onboarding, maintenance, and remote troubleshooting reduce total cost of ownership for providers. Finally, supply chain resilience and regulatory agility have become strategic imperatives; firms that embed redundancy and compliance-ready processes across their sourcing and production footprints can adapt more quickly to policy changes and clinical demand swings.
How cumulative tariff shifts in 2025 are influencing device sourcing, design priorities, procurement strategies, supplier partnerships, and distribution channel economics
The cumulative effects of recent tariff policy changes in 2025 are reshaping cost structures, sourcing strategies, and procurement behavior across the long-term care device ecosystem. Tariffs that increase the landed cost of imported components prompt manufacturers to reassess bill-of-materials decisions, prioritize local sourcing where feasible, and accelerate conversations about strategic nearshoring. These shifts influence product design choices, with procurement and engineering teams favoring component standardization and modular designs that permit substitution without sacrificing clinical functionality.
In parallel, providers and integrated delivery networks respond to higher input costs by tightening capital allocation, extending device lifecycles where clinically appropriate, and placing a premium on total cost of ownership analyses. This dynamic amplifies requirements for devices that are durable, serviceable, and supported by remote diagnostics to minimize downtime. For smaller suppliers and startups, tariff-driven margin pressure can constrain R&D investment, creating an environment where strategic partnerships, contract manufacturing agreements, and targeted licensing deals become more prevalent.
Moreover, distribution channels feel the impact differently: online platforms that aggregate suppliers can help absorb and redistribute cost pressures through broader sourcing options, while offline channels that rely on regional inventories must adapt pricing and inventory strategies. Across regions and end-user settings, these cumulative tariff dynamics incentivize diversification of supplier networks, heightened emphasis on supplier due diligence, and proactive engagement with payers and procurement officials to preserve access and affordability.
Segment-driven device strategies revealing distinct clinical, technical, and commercial priorities across diagnostic, mobility, and therapeutic categories aligned to product types and care settings
Insights drawn from a structured segmentation lens reveal distinct clinical, technical, and commercial priorities that vary across device categories, product types, channels, and end users. Based on Type, the Diagnostic category encompasses bed alarms, blood pressure monitors, ECG and Holter monitors, fall detection systems, glucose monitors, pulse oximeters, smart pill dispensers, smart wearables for monitoring, and thermometers, each of which places a premium on data accuracy, regulatory clearance, and ease of integration with clinical records. Mobility Assist includes crutches and canes, home medical furniture, walkers and rollators, and wheelchairs, where mechanical robustness, ergonomic design, and maintenance pathways dominate purchasing criteria. Therapeutic spans assistive communication devices, home dialysis equipment, home IV pumps, home respiratory care devices, insulin delivery systems, and wound care and pain management devices, categories that require rigorous safety engineering, caregiver training protocols, and close alignment with reimbursement rules.
When viewed by Product Type, non-wearable devices continue to hold a strong presence in institutional settings where fixed diagnostics and therapeutic equipment need reliability and serviceability, while wearable devices are increasingly favored in home care and remote monitoring scenarios due to their unobtrusive form factors and continuous data capabilities. Distribution Channel analysis distinguishes offline pathways, which remain essential for clinical sales, device installation, and service agreements, from online channels that facilitate direct procurement, rapid product discovery, and consumer-directed purchases in home care contexts. End Users such as assisted living facilities, home care settings, hospices and nursing homes, hospitals, and rehabilitation centers exhibit different procurement cadences, clinical staffing models, and regulatory constraints, driving varied product specifications and vendor relationship models. Taken together, these segmentation layers show that successful product strategies align technical specifications with the operational realities of target end users and distribution choices.
Regional dynamics and strategic responses shaping device adoption patterns, regulatory navigation, manufacturing footprints, procurement norms, and distribution pathways
Regional dynamics exert a powerful influence on supply chain decisions, regulatory pathways, and adoption patterns across the long-term care device landscape. In the Americas, demand profiles reflect a strong emphasis on home-based monitoring and integrated care models that connect primary care, specialists, and home health providers; regulatory systems prioritize safety and real-world evidence, while reimbursement frameworks increasingly reward outcomes that reduce avoidable hospitalizations. Consequently, manufacturers focus on interoperability and payer-aligned outcomes to improve adoption in both institutional and home care markets.
In Europe, the Middle East and Africa, regulatory variation is pronounced between markets, and procurement frequently occurs through centralized tenders or national health systems that emphasize cost-effectiveness and long-term supplier relationships. Manufacturers operating in this region must navigate diverse certification requirements and local clinical pathways, making harmonized compliance and adaptable service models key competitive levers. Across the Asia-Pacific region, rapid adoption of digital health tools coexists with expansive manufacturing capacity and growing investments in domestic production. This combination creates opportunities for technology transfer, contract manufacturing partnerships, and accelerated clinical validation pathways, but it also demands sensitivity to local reimbursement models and clinician workflows. Across all regions, cross-border trade policies, currency volatility, and logistics hubs shape where components are sourced and where final assembly occurs, requiring companies to tailor regional strategies that balance regulatory compliance, cost efficiency, and time-to-market.
Competitive positioning determined by modular product architectures, integrated clinical services, sensor performance, regulatory reach, and resilient supply chains
Competitive dynamics in the long-term care devices sector center on product differentiation through clinical value, operational reliability, and serviceability. Leading suppliers are investing in modular architectures that enable incremental feature upgrades, thereby reducing replacement cycles and aligning with provider procurement preferences. Strategic partnerships between device manufacturers, software vendors, and clinical service organizations are increasingly common, enabling bundled solutions that combine hardware, analytics, and clinical support to demonstrate care improvements and ease of implementation.
Innovation portfolios show a pronounced emphasis on sensor fidelity, battery life, and secure data transmission for monitoring devices, while therapeutic equipment development prioritizes patient comfort, fail-safe mechanisms, and remote servicing capabilities. In addition, companies are sharpening their commercial models: enterprise-focused offerings that include training, maintenance, and outcomes reporting appeal to larger institutional buyers, while a distinct set of consumer-oriented features and digital engagement tools matter more in the home care channel. Finally, supply chain resilience and regulatory expertise serve as differentiators; companies that can certify products across multiple jurisdictions and sustain component supply through diversified sourcing maintain higher trust among large healthcare purchasers.
Actionable operational, design, and commercial recommendations to mitigate cost risks, enhance interoperability, strengthen service models, and accelerate adoption across care settings
Industry leaders can take a set of actionable steps to secure adoption, manage cost pressures, and accelerate clinical integration. Firms should prioritize component standardization and modular design to reduce vulnerability to tariff-driven input cost volatility while enabling faster product updates. Concurrently, investing in robust interoperability layers and open APIs facilitates integration with electronic health records and telehealth platforms, which in turn simplifies payer and provider adoption pathways. From a commercial perspective, complementing traditional offline sales with scalable online distribution and digital marketing increases reach to home care purchasers and caregiver communities.
Operationally, companies should develop comprehensive service and remote diagnostics capabilities to lower total cost of ownership and reduce the need for in-person maintenance. Engaging early with payers and large purchasers to co-develop value demonstration pilots can shorten procurement cycles and clarify reimbursement pathways. Finally, building strategic partnerships with contract manufacturers or regional producers mitigates supply chain risk and supports nearshoring strategies. Together, these actions enable organizations to respond nimbly to policy shifts, clinical demand changes, and evolving user expectations while preserving innovation capacity.
Robust mixed-methods research approach combining practitioner interviews, regulatory review, device taxonomy alignment, case study validation, and scenario analysis for actionable insights
The underlying research employed a mixed-methods approach to ensure findings are triangulated and actionable. Primary qualitative interviews with clinicians, procurement leaders, and product engineers informed the interpretation of clinical workflows, device usability constraints, and purchasing rationales across care settings. These insights were complemented by secondary analysis of regulatory guidance, clinical literature, and publicly available supplier disclosures to map technology capabilities and compliance requirements.
To validate conclusions, the methodology combined expert consultations with cross-functional practitioners and a review of real-world deployment case studies that illustrate integration challenges and successful implementation patterns. Device categorizations followed a consistent taxonomy that distinguishes diagnostic, mobility assist, and therapeutic classes and layers in product type and channel considerations to produce segment-specific insights. Limitations include variability in regional regulatory timelines and the heterogeneity of procurement practices, which the study addresses through scenario-based analysis and sensitivity checks. Overall, the approach emphasizes qualitative depth, practitioner-validated findings, and pragmatic recommendations suitable for commercial and clinical decision-makers.
Concluding synthesis emphasizing strategic alignment of product design, regulatory approach, commercial models, and supply chain resilience to drive adoption and outcomes
In conclusion, the long-term care devices landscape demands strategic agility, technical rigor, and close alignment with the operational realities of care providers and patients. Technological advances-including improved wearables, smarter diagnostics, and remote-capable therapeutic systems-create opportunities to shift more care to home and community settings, but they also raise expectations for interoperability, data governance, and demonstrable clinical value. At the same time, policy developments and trade dynamics require supply chain diversification and cost-aware design choices that do not compromise safety or efficacy.
Consequently, organizations that synchronize product development, regulatory strategy, and commercial go-to-market plans will be better positioned to capture demand across assisted living facilities, home care settings, hospices and nursing homes, hospitals, and rehabilitation centers. Strategic investments in modular design, serviceability, interoperability, and payer engagement will deliver competitive advantage while supporting resilient operations. The insights presented here aim to help decision-makers prioritize initiatives that reduce risk, accelerate adoption, and improve patient outcomes in an evolving long-term care environment.
Please Note: PDF & Excel + Online Access - 1 Year
Strategic context for long-term care devices highlighting clinical shifts, care setting transitions, reimbursement interplay, and technology priorities for product leaders
The long-term care devices sector sits at the intersection of population aging, evolving care delivery models, and accelerating medical technology innovation. Clinicians, caregivers, and procurement leaders increasingly seek devices that enable safe, cost-effective care beyond traditional hospital walls, and that support clinical decision-making at the point of need. As a result, the ecosystem comprises a diverse array of product types and distribution pathways that must meet clinical requirements, regulatory standards, and user experience expectations simultaneously.
In practice, this landscape requires device manufacturers and service providers to think holistically about interoperability, data integrity, and ease of use. Remote monitoring and diagnostics are shifting care pathways toward the home and community settings, while mobility assist and therapeutic devices must balance durability with portability. Moreover, reimbursement frameworks and procurement cycles remain pivotal determinants of adoption. Consequently, stakeholders who align product design with care workflows and payer incentives gain a strategic edge.
Throughout this summary, the emphasis is on pragmatic insights that help leaders prioritize technology, channel, and partnership decisions. The narrative blends clinical, commercial, and regulatory lenses to illuminate how device categories, distribution choices, and regional dynamics shape competitive advantage and operational risk in long-term care.
Key transformative forces reshaping device design, distribution, interoperability expectations, clinical workflows, and supply chain resilience across long-term care settings
Several transformative shifts are redefining how long-term care devices are conceived, procured, and used across care settings. First, digital integration has moved from a differentiator to a baseline expectation: devices must interoperate securely with electronic health records, telehealth platforms, and caregiver dashboards to deliver actionable insights. This is accompanied by a rise in algorithm-enabled decision support that augments clinical workflows while creating new requirements for validation and regulatory clarity.
Second, the balance between wearable and non-wearable devices is evolving as advances in sensor miniaturization and power efficiency increase the clinical utility of wearables, while non-wearable devices continue to serve high-reliability diagnostic and therapeutic roles in institutional settings. Third, distribution dynamics are shifting as online procurement channels expand and hybrid models emerge where direct-to-consumer routes coexist with traditional supplier relationships.
Additionally, workforce constraints and the need for simplified device operation are elevating human-centered design. Companies that streamline onboarding, maintenance, and remote troubleshooting reduce total cost of ownership for providers. Finally, supply chain resilience and regulatory agility have become strategic imperatives; firms that embed redundancy and compliance-ready processes across their sourcing and production footprints can adapt more quickly to policy changes and clinical demand swings.
How cumulative tariff shifts in 2025 are influencing device sourcing, design priorities, procurement strategies, supplier partnerships, and distribution channel economics
The cumulative effects of recent tariff policy changes in 2025 are reshaping cost structures, sourcing strategies, and procurement behavior across the long-term care device ecosystem. Tariffs that increase the landed cost of imported components prompt manufacturers to reassess bill-of-materials decisions, prioritize local sourcing where feasible, and accelerate conversations about strategic nearshoring. These shifts influence product design choices, with procurement and engineering teams favoring component standardization and modular designs that permit substitution without sacrificing clinical functionality.
In parallel, providers and integrated delivery networks respond to higher input costs by tightening capital allocation, extending device lifecycles where clinically appropriate, and placing a premium on total cost of ownership analyses. This dynamic amplifies requirements for devices that are durable, serviceable, and supported by remote diagnostics to minimize downtime. For smaller suppliers and startups, tariff-driven margin pressure can constrain R&D investment, creating an environment where strategic partnerships, contract manufacturing agreements, and targeted licensing deals become more prevalent.
Moreover, distribution channels feel the impact differently: online platforms that aggregate suppliers can help absorb and redistribute cost pressures through broader sourcing options, while offline channels that rely on regional inventories must adapt pricing and inventory strategies. Across regions and end-user settings, these cumulative tariff dynamics incentivize diversification of supplier networks, heightened emphasis on supplier due diligence, and proactive engagement with payers and procurement officials to preserve access and affordability.
Segment-driven device strategies revealing distinct clinical, technical, and commercial priorities across diagnostic, mobility, and therapeutic categories aligned to product types and care settings
Insights drawn from a structured segmentation lens reveal distinct clinical, technical, and commercial priorities that vary across device categories, product types, channels, and end users. Based on Type, the Diagnostic category encompasses bed alarms, blood pressure monitors, ECG and Holter monitors, fall detection systems, glucose monitors, pulse oximeters, smart pill dispensers, smart wearables for monitoring, and thermometers, each of which places a premium on data accuracy, regulatory clearance, and ease of integration with clinical records. Mobility Assist includes crutches and canes, home medical furniture, walkers and rollators, and wheelchairs, where mechanical robustness, ergonomic design, and maintenance pathways dominate purchasing criteria. Therapeutic spans assistive communication devices, home dialysis equipment, home IV pumps, home respiratory care devices, insulin delivery systems, and wound care and pain management devices, categories that require rigorous safety engineering, caregiver training protocols, and close alignment with reimbursement rules.
When viewed by Product Type, non-wearable devices continue to hold a strong presence in institutional settings where fixed diagnostics and therapeutic equipment need reliability and serviceability, while wearable devices are increasingly favored in home care and remote monitoring scenarios due to their unobtrusive form factors and continuous data capabilities. Distribution Channel analysis distinguishes offline pathways, which remain essential for clinical sales, device installation, and service agreements, from online channels that facilitate direct procurement, rapid product discovery, and consumer-directed purchases in home care contexts. End Users such as assisted living facilities, home care settings, hospices and nursing homes, hospitals, and rehabilitation centers exhibit different procurement cadences, clinical staffing models, and regulatory constraints, driving varied product specifications and vendor relationship models. Taken together, these segmentation layers show that successful product strategies align technical specifications with the operational realities of target end users and distribution choices.
Regional dynamics and strategic responses shaping device adoption patterns, regulatory navigation, manufacturing footprints, procurement norms, and distribution pathways
Regional dynamics exert a powerful influence on supply chain decisions, regulatory pathways, and adoption patterns across the long-term care device landscape. In the Americas, demand profiles reflect a strong emphasis on home-based monitoring and integrated care models that connect primary care, specialists, and home health providers; regulatory systems prioritize safety and real-world evidence, while reimbursement frameworks increasingly reward outcomes that reduce avoidable hospitalizations. Consequently, manufacturers focus on interoperability and payer-aligned outcomes to improve adoption in both institutional and home care markets.
In Europe, the Middle East and Africa, regulatory variation is pronounced between markets, and procurement frequently occurs through centralized tenders or national health systems that emphasize cost-effectiveness and long-term supplier relationships. Manufacturers operating in this region must navigate diverse certification requirements and local clinical pathways, making harmonized compliance and adaptable service models key competitive levers. Across the Asia-Pacific region, rapid adoption of digital health tools coexists with expansive manufacturing capacity and growing investments in domestic production. This combination creates opportunities for technology transfer, contract manufacturing partnerships, and accelerated clinical validation pathways, but it also demands sensitivity to local reimbursement models and clinician workflows. Across all regions, cross-border trade policies, currency volatility, and logistics hubs shape where components are sourced and where final assembly occurs, requiring companies to tailor regional strategies that balance regulatory compliance, cost efficiency, and time-to-market.
Competitive positioning determined by modular product architectures, integrated clinical services, sensor performance, regulatory reach, and resilient supply chains
Competitive dynamics in the long-term care devices sector center on product differentiation through clinical value, operational reliability, and serviceability. Leading suppliers are investing in modular architectures that enable incremental feature upgrades, thereby reducing replacement cycles and aligning with provider procurement preferences. Strategic partnerships between device manufacturers, software vendors, and clinical service organizations are increasingly common, enabling bundled solutions that combine hardware, analytics, and clinical support to demonstrate care improvements and ease of implementation.
Innovation portfolios show a pronounced emphasis on sensor fidelity, battery life, and secure data transmission for monitoring devices, while therapeutic equipment development prioritizes patient comfort, fail-safe mechanisms, and remote servicing capabilities. In addition, companies are sharpening their commercial models: enterprise-focused offerings that include training, maintenance, and outcomes reporting appeal to larger institutional buyers, while a distinct set of consumer-oriented features and digital engagement tools matter more in the home care channel. Finally, supply chain resilience and regulatory expertise serve as differentiators; companies that can certify products across multiple jurisdictions and sustain component supply through diversified sourcing maintain higher trust among large healthcare purchasers.
Actionable operational, design, and commercial recommendations to mitigate cost risks, enhance interoperability, strengthen service models, and accelerate adoption across care settings
Industry leaders can take a set of actionable steps to secure adoption, manage cost pressures, and accelerate clinical integration. Firms should prioritize component standardization and modular design to reduce vulnerability to tariff-driven input cost volatility while enabling faster product updates. Concurrently, investing in robust interoperability layers and open APIs facilitates integration with electronic health records and telehealth platforms, which in turn simplifies payer and provider adoption pathways. From a commercial perspective, complementing traditional offline sales with scalable online distribution and digital marketing increases reach to home care purchasers and caregiver communities.
Operationally, companies should develop comprehensive service and remote diagnostics capabilities to lower total cost of ownership and reduce the need for in-person maintenance. Engaging early with payers and large purchasers to co-develop value demonstration pilots can shorten procurement cycles and clarify reimbursement pathways. Finally, building strategic partnerships with contract manufacturers or regional producers mitigates supply chain risk and supports nearshoring strategies. Together, these actions enable organizations to respond nimbly to policy shifts, clinical demand changes, and evolving user expectations while preserving innovation capacity.
Robust mixed-methods research approach combining practitioner interviews, regulatory review, device taxonomy alignment, case study validation, and scenario analysis for actionable insights
The underlying research employed a mixed-methods approach to ensure findings are triangulated and actionable. Primary qualitative interviews with clinicians, procurement leaders, and product engineers informed the interpretation of clinical workflows, device usability constraints, and purchasing rationales across care settings. These insights were complemented by secondary analysis of regulatory guidance, clinical literature, and publicly available supplier disclosures to map technology capabilities and compliance requirements.
To validate conclusions, the methodology combined expert consultations with cross-functional practitioners and a review of real-world deployment case studies that illustrate integration challenges and successful implementation patterns. Device categorizations followed a consistent taxonomy that distinguishes diagnostic, mobility assist, and therapeutic classes and layers in product type and channel considerations to produce segment-specific insights. Limitations include variability in regional regulatory timelines and the heterogeneity of procurement practices, which the study addresses through scenario-based analysis and sensitivity checks. Overall, the approach emphasizes qualitative depth, practitioner-validated findings, and pragmatic recommendations suitable for commercial and clinical decision-makers.
Concluding synthesis emphasizing strategic alignment of product design, regulatory approach, commercial models, and supply chain resilience to drive adoption and outcomes
In conclusion, the long-term care devices landscape demands strategic agility, technical rigor, and close alignment with the operational realities of care providers and patients. Technological advances-including improved wearables, smarter diagnostics, and remote-capable therapeutic systems-create opportunities to shift more care to home and community settings, but they also raise expectations for interoperability, data governance, and demonstrable clinical value. At the same time, policy developments and trade dynamics require supply chain diversification and cost-aware design choices that do not compromise safety or efficacy.
Consequently, organizations that synchronize product development, regulatory strategy, and commercial go-to-market plans will be better positioned to capture demand across assisted living facilities, home care settings, hospices and nursing homes, hospitals, and rehabilitation centers. Strategic investments in modular design, serviceability, interoperability, and payer engagement will deliver competitive advantage while supporting resilient operations. The insights presented here aim to help decision-makers prioritize initiatives that reduce risk, accelerate adoption, and improve patient outcomes in an evolving long-term care environment.
Please Note: PDF & Excel + Online Access - 1 Year
Table of Contents
196 Pages
- 1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency
- 1.5. Language
- 1.6. Stakeholders
- 2. Research Methodology
- 3. Executive Summary
- 4. Market Overview
- 5. Market Insights
- 5.1. Integration of wearable health sensors with remote monitoring platforms for elderly care
- 5.2. Adoption of AI-driven predictive analytics to prevent hospitalization in home care settings
- 5.3. Deployment of fall detection systems with machine learning algorithms to reduce emergency incidents at assisted living facilities
- 5.4. Development of antimicrobial surface coatings on mobility devices to lower infection risks among long term patients
- 5.5. Utilization of telepresence robots for daily check-ins and social engagement in remote care environments
- 5.6. Implementation of smart infusion pumps with closed-loop drug delivery to enhance medication adherence in long term care
- 5.7. Integration of voice-activated virtual assistants to streamline medication reminders and health reporting in nursing homes
- 5.8. Expansion of home dialysis devices featuring compact design and real-time monitoring for patient autonomy at home
- 6. Cumulative Impact of United States Tariffs 2025
- 7. Cumulative Impact of Artificial Intelligence 2025
- 8. Long Term Care Devices Market, by Type
- 8.1. Diagnostic
- 8.1.1. Bed Alarms
- 8.1.2. Blood Pressure Monitors
- 8.1.3. ECG & Holter Monitors
- 8.1.4. Fall Detection Systems
- 8.1.5. Glucose Monitors
- 8.1.6. Pulse Oximeters
- 8.1.7. Smart Pill Dispensers
- 8.1.8. Smart Wearables for Monitoring
- 8.1.9. Thermometers
- 8.2. Mobility Assist
- 8.2.1. Crutches & Canes
- 8.2.2. Home Medical Furniture
- 8.2.3. Walkers & Rollators
- 8.2.4. Wheelchair
- 8.3. Therapeutic
- 8.3.1. Assistive Communication Devices
- 8.3.2. Home Dialysis Equipment
- 8.3.3. Home IV Pumps
- 8.3.4. Home Respiratory Care Devices
- 8.3.5. Insulin Delivery
- 8.3.6. Wound Care & Pain Management Devices
- 9. Long Term Care Devices Market, by Product Type
- 9.1. Non-Wearable Devices
- 9.2. Wearable Devices
- 10. Long Term Care Devices Market, by Distribution Channel
- 10.1. Offline
- 10.2. Online
- 11. Long Term Care Devices Market, by End Users
- 11.1. Assisted Living Facilities
- 11.2. Home Care Settings
- 11.3. Hospices & Nursing Homes
- 11.4. Hospitals
- 11.5. Rehabilitation Centers
- 12. Long Term Care Devices Market, by Region
- 12.1. Americas
- 12.1.1. North America
- 12.1.2. Latin America
- 12.2. Europe, Middle East & Africa
- 12.2.1. Europe
- 12.2.2. Middle East
- 12.2.3. Africa
- 12.3. Asia-Pacific
- 13. Long Term Care Devices Market, by Group
- 13.1. ASEAN
- 13.2. GCC
- 13.3. European Union
- 13.4. BRICS
- 13.5. G7
- 13.6. NATO
- 14. Long Term Care Devices Market, by Country
- 14.1. United States
- 14.2. Canada
- 14.3. Mexico
- 14.4. Brazil
- 14.5. United Kingdom
- 14.6. Germany
- 14.7. France
- 14.8. Russia
- 14.9. Italy
- 14.10. Spain
- 14.11. China
- 14.12. India
- 14.13. Japan
- 14.14. Australia
- 14.15. South Korea
- 15. Competitive Landscape
- 15.1. Market Share Analysis, 2024
- 15.2. FPNV Positioning Matrix, 2024
- 15.3. Competitive Analysis
- 15.3.1. Abbott Laboratories
- 15.3.2. ARKRAY Inc.
- 15.3.3. Asahi Kasei Corporation
- 15.3.4. B. Braun SE
- 15.3.5. Baxter International Inc.
- 15.3.6. Becton, Dickinson and Company
- 15.3.7. BMC Medical Co., Ltd.
- 15.3.8. Boston Scientic Corporation
- 15.3.9. Cardinal Health, Inc.
- 15.3.10. Compass Health Brands
- 15.3.11. Drive DeVilbiss Healthcare
- 15.3.12. F. Hoffmann-La Roche Ltd.
- 15.3.13. Fresenius Medical Care AG
- 15.3.14. GE HealthCare
- 15.3.15. Getinge AB
- 15.3.16. GF Health Products, Inc.
- 15.3.17. Honeywell International Inc.
- 15.3.18. Invacare Holdings Corporation
- 15.3.19. Johnson & Johnson Services Inc.
- 15.3.20. Koninklijke Philips N.V.
- 15.3.21. Linde PLC
- 15.3.22. Medline Industries, LP
- 15.3.23. Medtronic PLC
- 15.3.24. Omron Corporation
- 15.3.25. PHC Holdings Corporation
- 15.3.26. ResMed Inc.
- 15.3.27. Siemens Healthineers AG
- 15.3.28. Solventum
- 15.3.29. Sunrise Medical LLC
- 15.3.30. Vayyar Care
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
